“As we move into 2023, NABC is focused on ramping up our presence in Washington D.C., to ensure members of Congress understand the scope, scale, and benefits of the highbush […]
Horizon’s Joel White was interviewed by The New York Times about Sen. Bernie Sanders new role as head of the Senate Health Committee. Joel White, a Republican strategist who specializes […]
Contact: Anna Nix Kumar(605) 201-7702akumar@monumentadvocacy.com Monument Adds Tech Expert Troy StockTroy to Advise Clients on Federal Privacy and Data Issues Shaping Future of Sector Washington, DC – Monument Advocacy today […]
Horizon CEO Joel White shared his insights on the impact 2022 had on health policy during “The Year Ahead in Health Policy” webinar sponsored by The Commonwealth Fund. The Benefits […]
January 23, 2023 “The divided government creates a lot of need for political intelligence,” said Stewart Verdery, CEO of Monument Advocacy, whose clients include some of the top 10 spenders, […]
January 23, 2023 KEEPING AN EYE ON SCOTUS: The Supreme Court will take up cases on several hot-button social issues this year, and though some of the most contentious cases on […]
Inside Health Policy included Horizon’s and the Council for Affordable Health Coverage’s efforts to increase interest in value-based payment arrangements for high cost drugs. Joel White, president and CEO of […]
January 21, 2023 “If you’re the opposition and the other party has committed a foul, pre-Clinton there was a hesitation to rush to judgment — the innocent-until-proven guilty sort of […]
This month’s Horizon Highlight spotlights key Congressional Committees and their leadership.*At the time of posting, not all seats had officially been filled.
January 7, 2023 “You’re going to have a sword of Damocles above any speaker over any actual or perceived dalliance with bipartisanship,” said Stewart Verdery, a former GOP Senate aide […]
Joel White spoke with Inside Drug Pricing about the Biden Adminstration’s growing interest in value-based payments for prescription drugs. CMS’ Center for Medicare and Medicaid Innovation (CMMI) is considering testing […]
Horizon CEO, Joel White, spoke to Inside Health Policy about how the Inflation Reduction Act’s drug pricing negotiations will impact the pharmaceutical industry. Horizon Government Affairs President and Founder Joel […]